LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4

International Journal of Cardiology
Xiaoxiong XiaoYongjun Wang

Abstract

Emerging evidences have indicated that long non-coding RNAs (lncRNAs) play vital roles in cardiovascular physiology and pathology. The lncRNA MALAT1, a highly abundant and conserved imprinted gene, has been implicated in many cardiovascular diseases. However, the function of MALAT1 in calcific aortic valve disease (CAVD) remains unknown. This study sought to document the function and underlying mechanism of MALAT1 in regulating CAVD. Protein level was determined by immunoblotting and immunofluorescence staining. MALAT1, miR-204 and mRNA expressions were detected by qRT-PCR. Mineralized bone matrix formation was assessed by Alizarin Red staining. The interaction between MALAT1 and miR-204 was studied using luciferase reporter assay, RNA pull-down assay and RNA-binding protein immunoprecipitation assay. Ectopic expression of MALAT1 was observed in calcific valves and after osteogenic induction in human aortic valve interstitial cells (VICs). In vitro experiments revealed that MALAT1 acted as a positive regulator of osteogenic differentiation by repressing miR-204 expression and activity and thereby promoting expression of osteoblast-specific markers, including alkaline phosphatase, mineralized bone matrix formation and osteocalci...Continue Reading

Citations

Nov 7, 2017·Clinical Implant Dentistry and Related Research·Wei PengSong-Ling Chen
Feb 14, 2018·Journal of Cardiovascular Pharmacology·Wen-Juan NiXiao-Min Leng
Aug 23, 2018·Journal of Cellular Physiology·Li LeiQinghai Zeng
Jun 29, 2018·American Journal of Physiology. Lung Cellular and Molecular Physiology·Hua JiangHaihai Liang
Oct 20, 2018·Journal of Cellular and Molecular Medicine·Lingjia YuGuixing Qiu
Apr 21, 2018·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Qiao ZhangNianguo Dong
Jun 27, 2019·International Journal of Immunopathology and Pharmacology·Shuquan WeiZiwen Zhao
Jul 25, 2019·Molecular & Cellular Proteomics : MCP·Anja M BillingJohannes Graumann
Sep 5, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Dijie LiAirong Qian
Mar 15, 2018·Stem Cells International·Shuping PengCijun Shuai
Nov 22, 2018·Frontiers in Cardiovascular Medicine·Vinal Menon, Joy Lincoln
Oct 24, 2018·Frontiers in Endocrinology·Qian-Yuan WuFeng Lai Yuan
Mar 28, 2019·Bone & Joint Research·J ZhangF Guo
Sep 13, 2020·Non-coding RNA·Lavinia RaimondiNicola Amodio
Feb 6, 2019·Molecular Medicine Reports·Fei LinGuhao Zhang
Jul 30, 2018·Aging Medicine·Jieyu HeYoushuo Liu
Mar 13, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Philip Roger GoodyFelix Jansen
Feb 6, 2020·Clinical and Translational Medicine·Estanislao NavarroMiguel Hueso
May 8, 2018·Journal of Cardiovascular Pharmacology·Wen-Juan NiXiao-Min Leng
May 29, 2018·Journal of Cellular Biochemistry·Gino NardocciMartín Montecino
May 10, 2020·International Journal of Oral Science·Ruilin ZhangYao Sun
Oct 7, 2020·The Journal of International Medical Research·Junyi HongWei Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.